Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Pretomanid
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : TB Alliance
Deal Size : Undisclosed
Deal Type : Partnership
Details : Under the partnership, Remington will commercialize the anti-tuberculosis medicine, pretomanid as part of the all-oral, six-month BPaL and BPaLM regimens for treatment of drug-resistant TB (comprised of bedaquiline, pretomanid, and linezolid) in Pakistan...
Brand Name : Pretomanid-Generic
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 14, 2023
Lead Product(s) : Pretomanid
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : TB Alliance
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?